ENvue Medical (FEED) Net Cash Flow Growth (1y) (2015 - 2026)
ENvue Medical (FEED) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -54.17% |
| 10 | ENvue Medical | 2.50 Mn | 1.36 Mn | -266,000.00 | -132.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -132.46% |
| Mar 31, 2026 | -1,226.00% |
| Dec 31, 2025 | -398.72% |
| Sep 30, 2025 | 438.59% |
| Jun 30, 2025 | 723.96% |
| Mar 31, 2025 | 74.14% |
| Dec 31, 2024 | -11.61% |
| Sep 30, 2024 | -124.43% |
| Jun 30, 2024 | 54.84% |
| Mar 31, 2024 | 51.42% |
| Dec 31, 2023 | 63.08% |
| Sep 30, 2023 | 279.70% |
| Jun 30, 2023 | 38.52% |
| Mar 31, 2023 | 31.42% |
| Dec 31, 2022 | -54.11% |
| Sep 30, 2022 | -167.17% |
| Jun 30, 2022 | 13.24% |
| Mar 31, 2022 | -486.89% |
| Dec 31, 2021 | -121.91% |
| Sep 30, 2021 | -12.05% |